JP2020518651A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020518651A5 JP2020518651A5 JP2019561277A JP2019561277A JP2020518651A5 JP 2020518651 A5 JP2020518651 A5 JP 2020518651A5 JP 2019561277 A JP2019561277 A JP 2019561277A JP 2019561277 A JP2019561277 A JP 2019561277A JP 2020518651 A5 JP2020518651 A5 JP 2020518651A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- pharmaceutical composition
- abu
- fine particles
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762502913P | 2017-05-08 | 2017-05-08 | |
| US62/502,913 | 2017-05-08 | ||
| PCT/US2018/031663 WO2018208829A1 (en) | 2017-05-08 | 2018-05-08 | Biodegradable microparticles for sustained delivery of anti-angiogenic peptide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020518651A JP2020518651A (ja) | 2020-06-25 |
| JP2020518651A5 true JP2020518651A5 (https=) | 2021-07-26 |
Family
ID=64104968
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019561277A Withdrawn JP2020518651A (ja) | 2017-05-08 | 2018-05-08 | 抗血管新生ペプチドの持続送達のための生分解性微粒子 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20200179285A1 (https=) |
| EP (1) | EP3621597A4 (https=) |
| JP (1) | JP2020518651A (https=) |
| KR (1) | KR20200003859A (https=) |
| CN (1) | CN111315364A (https=) |
| AU (1) | AU2018266690A1 (https=) |
| CA (1) | CA3063140A1 (https=) |
| WO (1) | WO2018208829A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112019021056B1 (pt) | 2017-04-06 | 2022-11-22 | Sustain Holdings, Llc | Usos de uma composição que compreende um peptídeo mimético de colágeno para o tratamento ou a prevenção de uma doença, distúrbio ou ferida ocular |
| US11674959B2 (en) | 2017-08-03 | 2023-06-13 | The Johns Hopkins University | Methods for identifying and preparing pharmaceutical agents for activating Tie1 and/or Tie2 receptors |
| AU2020248438A1 (en) | 2019-03-26 | 2021-10-28 | Asclepix Therapeutics, Inc. | Compositions and methods for treating ocular disease |
| EP3958889B1 (en) | 2019-04-22 | 2025-01-08 | Sustain Holdings, LLC | Collagen mimetic peptide compositions for treating a posterior segment ocular disease or disorder involving the retina, retinal blood vessels, retinal nerves or optic nerve |
| IT202100023357A1 (it) | 2021-09-09 | 2023-03-09 | Cheirontech S R L | Peptidi con attività anti-angiogenica |
| CN117126233A (zh) * | 2022-05-20 | 2023-11-28 | 杭州禾泰健宇生物科技有限公司 | 一种类肽化合物及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9717694B2 (en) * | 2009-05-15 | 2017-08-01 | The Johns Hopkins University | Peptide/particle delivery systems |
| US10314917B2 (en) * | 2013-03-15 | 2019-06-11 | The Brigham And Women's Hospital, Inc. | Targeted polymeric inflammation-resolving nanoparticles |
| US9802984B2 (en) * | 2013-06-07 | 2017-10-31 | The Johns Hopkins University | Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases |
| MX2019003895A (es) * | 2016-10-04 | 2019-10-07 | Asclepix Therapeutics Inc | Compuestos y metodos para activar la señalizacion tie2. |
-
2018
- 2018-05-08 CA CA3063140A patent/CA3063140A1/en not_active Abandoned
- 2018-05-08 KR KR1020197035367A patent/KR20200003859A/ko not_active Ceased
- 2018-05-08 AU AU2018266690A patent/AU2018266690A1/en not_active Abandoned
- 2018-05-08 CN CN201880039876.3A patent/CN111315364A/zh active Pending
- 2018-05-08 US US16/612,124 patent/US20200179285A1/en not_active Abandoned
- 2018-05-08 EP EP18797771.5A patent/EP3621597A4/en not_active Withdrawn
- 2018-05-08 WO PCT/US2018/031663 patent/WO2018208829A1/en not_active Ceased
- 2018-05-08 JP JP2019561277A patent/JP2020518651A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020518651A5 (https=) | ||
| Ward et al. | Neuroprotection of retinal ganglion cells in DBA/2J mice with GDNF-loaded biodegradable microspheres | |
| JP6700348B2 (ja) | 持続型薬物送達インプラント | |
| JP2018500394A5 (https=) | ||
| JP2008528446A5 (https=) | ||
| ES2782111T3 (es) | Micropartículas cargadas con ciclosporina de liberación sostenida | |
| JP2019535651A5 (https=) | ||
| US9044436B2 (en) | Compositions and methods for the treatment of angiogenesis-related eye diseases | |
| JP2020518651A (ja) | 抗血管新生ペプチドの持続送達のための生分解性微粒子 | |
| CA2891365A1 (en) | Composition for immediate and extended release | |
| CN1638734A (zh) | 微粒结膜下给药的药物释放系统 | |
| US20150306170A1 (en) | Composition for immediate and extended release | |
| CN108697810A (zh) | 用于剂的控制释放的聚合物复合材料 | |
| JP2025118607A5 (https=) | ||
| JPWO2021195163A5 (https=) | ||
| RU2409348C2 (ru) | Лекарственные составы с контролируемым высвобождением, основанные на блок-сополимерах | |
| RU2476235C2 (ru) | Композиции на основе биосовместимых микрочастиц альгиновой кислоты, предназначенные для регулируемого высвобождения активных ингредиентов при внутривенном введении | |
| KR101732609B1 (ko) | 생리활성물질의 순차적 방출제어를 위한 고분자 혼합 제제 | |
| TWI660740B (zh) | 水膠組合物及包含其之藥物傳輸系統 | |
| CN107970204B (zh) | 水凝胶组合物及包含其的药物递送系统 | |
| Karagoz et al. | Producing Aflibercept Loaded Poly (Lactic Co Glycolic Acid)[Plga] Nanoparticles As A New Ocular Drug Delivery System and Its Challenges | |
| JPWO2020247625A5 (https=) | ||
| CN120267619A (zh) | 一种奥氮平长效缓释微球制剂及其制备方法与应用 | |
| CN104906587B (zh) | 一种膦甲酸钠眼玻璃体腔内缓释药物 | |
| CN104958762B (zh) | 一种33g针头注射用雷珠单抗眼玻璃体腔内缓释药物 |